Synthesis and activity of fluorinated derivatives of sulindac sulphide and sulindac sulphone

Pharmacy and Pharmacology Communications

Volumn 6, Issue 5, 2000, Pages 217-221

  Jung, Manfred ^a   Wahl, Alan F ^b   Neupert, Werner ^c   Geisslinger, Gerd ^c   Senter, Peter D ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b SEATTLE GENETICS INC   (United States)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SULINDAC; SULINDAC SULFIDE; SULINDAC SULFONE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CANCER; CYTOTOXICITY; DRUG SYNTHESIS; FLUORINATION; HUMAN; HUMAN CELL;

EID: 0034115736     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080800128735926     Document Type: Article

References (26)

1. Chan, T. A., Morin, P. J., Vogelstein, B., Kinzler, K. W. (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl Acad. Sci. USA 95: 681-686
2. De Lucchi, O., Miotti, U., Modena, G. (1991) The Pummerer reaction of sulphinyl compounds. Org. Reactions 40: 157-405
3. Duggan, D. E., Hooke, K. F., Risley, E. A. Shen, T. Y., Arman, C. G. (1977) Identification of the biologically active form of sulindac. J. Pharmacol. Exp. Ther. 201: 8-13
4. Elder, D. J. E., Paraskeva, C. (1997) NSAIDS to prevent colorectal cancer: a question of sensitivity. Gastroenterology 113: 1999-2003
5. Filler, R., Kobayashi, K., Yagupolskii L. M. (eds) (1993) Organofluorine compounds. In: Medicinal Chemistry and Biomedical Applications. Elsevier, Amsterdam
6. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., Offerhaus, G. J. (1993) Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328: 1313-1316
7. Hakama, M. (1998) Chemoprevention of cancer. Acta Oncol. 37: 227-230
8. He, T. C., Chan, T. A., Vogelstein, B., Kinzler, K. W. (1999) PPAR delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345
9. Herrmann, C., Block, C., Geisen, C., Haas, K., Weber, C., Winde, G., Moroy, T., Müller, O. (1998) Sulindac sulfide inhibits ras signaling. Oncogene 17: 1769-1776
10. Jones, H. (1975) 5-Fluoro-2-methyl-1-(p-methysulfinylbenzylidene)-indenyl-3-acetic acid. U.S. Pat. 3869507
11. Kahn, M. J., Morrison, D. G. (1997) Chemoprevention for colorectal carcinoma. Hematol. Oncol. Clin. North Am. 11: 779-794
12. Kelloff, G. J., Boone, C. W., Steele, V. E., Fay, J. R., Lubet, R. A., Crowell, J. A., Sigman, C. C. (1995) Mechanistic considerations in chemopreventive drug development. J. Cell. Biochem. Suppl. 20: 1-24
13. Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., Kliewer, S. A. (1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272: 3406-3410
14. McCarthy, J. R., Peet, N. P., LeTourneau, M. E., Inbasekaran, M. (1985) (Diethylamino)sulfur trifluoride in organic synthesis. 2. The transformation of sulfoxides to α-fluoro thioethers. J. Am. Chem. Soc. 107: 735-737
15. Neupert, W., Brugger, R., Euchenhofer, C., Brune, K., Geisslinger, G. (1997) Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Br. J. Pharmacol. 122: 487-492
16. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., Taketo, M. M. (1996) Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809
17. Panara, M. R., Greco, A., Santini, G., Sciulli, M. G., Rotondo, M. T., Padovano, R., Digiamberardino, M., Cipollone, F., Cuccurullo, F., Patrono, C., Patrignani, P. (1995) Effects of the novel antiinflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (Ns-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. Br. J. Pharmacol. 116: 2429-2434
18. Piazza, G. A., Rahm, A. L. K., Krutzsch, M., Sperl, G., Paranka, N. S., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D. S., Pamukcu, R., Ahnen, D. J. (1995) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55: 3110-3116
19. Shiff, S. J., Qiao, L., Tsai, L. L., Rigas, B. (1995) Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96: 491-503
20. Shuman, R. F., Pines, S. H., Shearin, W. E., Czaja, R. F., Abramson, N. L., Tull, R. (1977) A sterically efficient synthesis of (Z)-5-fluoro-2-methyl-1-(p-methylthiobenzylidene)-3-indenylacetic acid and its S-oxide, sulindac. J. Org. Chem. 42: 1914-1919
21. Thompson, H. J., Briggs, S., Paranka, N. S., Piazza, G. A., Brendel, K., Gross, P. H., Sperl, G. J., Pamukcu, R., Ahnen, D. J. (1995) Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J. Natl Cancer. Inst. 87: 1259-1260
22. Thompson, H. J., Jiang, C., Lu, J., Mehta, R. G., Piazza, G. A., Paranka, N. S., Pamukcu, R., Ahnen, D. J. (1997) Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res. 57: 267-271
23. Verheul, H. M., Panigraphy, D., Yuan, J., D'Amato, R. J. (1999) Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumor growth in rabbits. Br. J. Cancer 79: 114-118
24. Waddell, W. R. (1998) Stimulation of apoptosis by sulindac and piroxicam. Clin. Sci. Colch. 95: 385-388
25. Wattenberg, L. W. (1997) An overview of chemoprevention: current status and future prospects. Proc. Soc. Exp. Biol. Med. 216: 133-141
26. Welch, J. T., Eswarakrishnan, S. (1991) Fluorine in Bioorganic Chemistry. Wiley, New York